www.fdanews.com/articles/121771-impax-challenges-abbott-8217-s-patents-in-connection-to-tricor

Impax Challenges Abbott’s Patents in Connection to Tricor

October 30, 2009

Impax Laboratories, Inc. has initiated a challenge of the patents listed by Abbott Laboratories in connection with its TRICOR (fenofibrate) tablets, 48 mg and 145 mg.
StreetInsider